|
2016 Journal Article Risk factors for current and future unmet supportive care needs of people with pancreatic cancer. A longitudinal study (vol 24, pg 3589, 2016)Beesley, Vanessa L., Wockner, Leesa F., O'Rourke, Peter, Janda, Monika, Goldstein, David, Gooden, Helen, Merrett, Neil D., O'Connell, Dianne L., Rowlands, Ingrid J., Wyld, David K. and Neale, Rachel E. (2016). Risk factors for current and future unmet supportive care needs of people with pancreatic cancer. A longitudinal study (vol 24, pg 3589, 2016). Supportive Care in Cancer, 24 (8), 3601-3602. doi: 10.1007/s00520-016-3251-x |
|
2016 Conference Publication A single center experience of cardiac metastasis from neuroendocrine tumors (net)Ladwa, Rahul, Burge, Matthew and Wyld, David (2016). A single center experience of cardiac metastasis from neuroendocrine tumors (net). COSA's 43 and ANZBCTG's 38 Annual Scientific Meetings. Partners for Progress in Breast Cancer Research and Care, Gold Coast, QLD Australia, 15-17 November 2016. Chichester, West Sussex United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12646 |
|
2016 Conference Publication How Long Is the Piece of String? - How Patients Negotiate the Uncertainties of a NET DiagnosisWyld, D., Plage, S., Burge, M., Broom, A., Lwin, Z., McDade, H. and Cubitt, A. (2016). How Long Is the Piece of String? - How Patients Negotiate the Uncertainties of a NET Diagnosis. 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, Mar 09-11, 2016. Basel, Switzerland: S. Karger AG. doi: 10.1159/000448725 |
|
2016 Conference Publication Dosimetry to Estimate the Effect of Gelofusine (R) on the Renal Absorbed Dose of Lutetium 177-DOTA-OctreotateLucas, C., Goodman, S., Smith, J., Burge, M., Wyld, D. and Kumar, Ravi A. (2016). Dosimetry to Estimate the Effect of Gelofusine (R) on the Renal Absorbed Dose of Lutetium 177-DOTA-Octreotate. 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, Mar 09-11, 2016. Basel, Switzerland: S. Karger AG. doi: 10.1159/000448725 |
|
2016 Conference Publication Availability and Utility of Functional Imaging (FI) and Peptide Receptor Radionuclide Therapy (PRRT) in the CommNETS Collaboration (Australia, Canada and New Zealand)Chan, B. A., Sim, H-W., Ravikumar, A., Bailey, D., Chan, D., Lawrence, B., McEwan, A., Pavlakis, N., Segelov, E., Singh, S., Roach, P. and Wyld, D. (2016). Availability and Utility of Functional Imaging (FI) and Peptide Receptor Radionuclide Therapy (PRRT) in the CommNETS Collaboration (Australia, Canada and New Zealand). Oxford, United Kingdom: Oxford University Press. |
|
2016 Conference Publication Unplanned admissions to a medical oncology unit at a tertiary hospital - an analysis of emergency presentationsGunawan, Ben, Button, Elise, Bates, Tracey, Nasato, Gillian and Wyld, David (2016). Unplanned admissions to a medical oncology unit at a tertiary hospital - an analysis of emergency presentations. COSA's 43 and ANZBCTG's 38 Annual Scientific Meetings. Partners for Progress in Breast Cancer Research and Care, Gold Coast, QLD Australia, 15-17 November 2016. Chichester, West Sussex United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12646 |
|
2016 Conference Publication Pretherapy Identification of Patients at Risk of Receiving a High Renal Dose Undergoing Peptide Receptor Radionuclide TherapyGoodman, S., Smith, J., Kumar, Ravi A., Wyld, D. and Burge, M. (2016). Pretherapy Identification of Patients at Risk of Receiving a High Renal Dose Undergoing Peptide Receptor Radionuclide Therapy. 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, Mar 09-11, 2016. Basel, Switzerland: S. Karger AG. doi: 10.1159/000448725 |
|
2016 Conference Publication A systematic review and meta-analysis of patient reporting outcomes in clinical practiceRoberts, Natasha, Janda, Monika, Alexander, Kimberley and Wyld, David (2016). A systematic review and meta-analysis of patient reporting outcomes in clinical practice. COSA's 43rd and ANZBCTG's 38th Annual Scientific Meetings. Partners for Progress in Breast Cancer Research and Care, Gold Coast, Australia, 15–17 November 2016. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12635_4 |
|
2016 Conference Publication Optimizing adjuvant chemotherapy delivery in older women with breast cancer - a reviewKalas, Timothy S. and Wyld, David (2016). Optimizing adjuvant chemotherapy delivery in older women with breast cancer - a review. COSA's 43 and ANZBCTG's 38 Annual Scientific Meetings. Partners for Progress in Breast Cancer Research and Care, Gold Coast International Hotel, Gold Coast, Queensland, Australia,, Gold Coast, QLD Australia. Chichester, West Sussex United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12646 |
|
2016 Conference Publication A Single Centres Experience of Cardiac Metastasis from Neuroendocrine Tumours (NET)Ladwa, R., Burge, M. and Wyld, D. (2016). A Single Centres Experience of Cardiac Metastasis from Neuroendocrine Tumours (NET). 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, Mar 09-11, 2016. Basel, Switzerland: S. Karger AG. doi: 10.1159/000448725 |
|
2016 Conference Publication A prospective 2-year experience of a medical oncology advanced trainee in QueenslandLadwa, Rahul, Chern, Boris, Sanmugarajah, Jasotha and Wyld, David (2016). A prospective 2-year experience of a medical oncology advanced trainee in Queensland. COSA's 43 and ANZBCTG's 38 Annual Scientific Meetings. Partners for Progress in Breast Cancer Research and Care, Gold Coast, QLD Australia, 15-17 November 2016. Chichester, West Sussex United Kingdom: Wiley-Blackwell Publishing. |
|
2016 Journal Article RAD51B in familial breast cancerPelttari, Liisa M., Khan, Sofia, Vuorela, Mikko, Kiiski, Johanna I., Vilske, Sara, Nevanlinna, Viivi, Ranta, Salla, Schleutker, Johanna, Winqvist, Robert, Kallioniemi, Anne, Dörk, Thilo, Bogdanova, Natalia V., Figueroa, Jonine, Pharoah, Paul D. P., Schmidt, Marjanka K., Dunning, Alison M., García-Closas, Montserrat, Bolla, Manjeet K., Dennis, Joe, Michailidou, Kyriaki, Wang, Qin, Hopper, John L., Southey, Melissa C., Rosenberg, Efraim H., Fasching, Peter A., Beckmann, Matthias W., Peto, Julian, Dos-Santos-silva, Isabel, Sawyer, Elinor J. ... Zeps, N. (2016). RAD51B in familial breast cancer. PLoS One, 11 (5) e0153788, e0153788. doi: 10.1371/journal.pone.0153788 |
|
2016 Journal Article Hope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancerSchofield, Penelope E., Stockler, M. R., Zannino, D., Tebbutt, N. C., Price, T. J., Simes, R. J., Wong, N., Pavlakis, N., Ransom, D., Moylan, E., Underhill, C., Wyld, D., Burns, I., Ward, R., Wilcken, N. and Jefford, M. (2016). Hope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancer. Supportive Care in Cancer, 24 (1), 401-408. doi: 10.1007/s00520-015-2792-8 |
|
2016 Conference Publication The Difficulties of Response Assessment after Peptide Receptor Radionucleotide Therapy (PRRT): An Unusual Case of Symptomatic PseudoprogressionLadwa, R., Lyle, M., Wyld, D. and Burge, M. (2016). The Difficulties of Response Assessment after Peptide Receptor Radionucleotide Therapy (PRRT): An Unusual Case of Symptomatic Pseudoprogression. 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, Mar 09-11, 2016. Basel, Switzerland: S. Karger AG. doi: 10.1159/000448725 |
|
2015 Journal Article High-throughput amplicon-based copy number detection of 11 genes in formalin-fixed paraffin-embedded ovarian tumour samples by MLPA-seqKondrashova,Olga, Love, Clare J., Lunke, Sebastian, Hsu, Arthur L., Waring, Paul M., Taylor, Graham R., Australian Ovarian Cancer Study (AOCS) Group, Chenevix-Trench, G. and Wyld, D. (2015). High-throughput amplicon-based copy number detection of 11 genes in formalin-fixed paraffin-embedded ovarian tumour samples by MLPA-seq. PLoS One, 10 (11) e0143006, 1-14. doi: 10.1371/journal.pone.0143006 |
|
2015 Journal Article A prospective study of the impact of fluorodeoxyglucose positron emission tomography with concurrent non-contrast CT scanning on the management of operable pancreatic and peri-ampullary cancersBurge, Matthew E., O'Rourke, Nick, Cavallucci, David, Bryant, Richard, Francesconi, Alessandra, Houston, Kathleen, Wyld, David, Eastgate, Melissa, Finch, Robert, Hopkins, George, Thomas, Paul and Macfarlane, David (2015). A prospective study of the impact of fluorodeoxyglucose positron emission tomography with concurrent non-contrast CT scanning on the management of operable pancreatic and peri-ampullary cancers. HPB, 17 (7), 624-631. doi: 10.1111/hpb.12418 |
|
2015 Journal Article A tsunami of unmet needs: pancreatic and ampullary cancer patients' supportive care needs and use of community and allied health servicesBeesley, Vanessa L., Janda, Monika, Goldstein, David, Gooden, Helen, Merrett, Neil D., O'Connell, Dianne L., Rowlands, Ingrid J., Wyld, David and Neale, Rachel E. (2015). A tsunami of unmet needs: pancreatic and ampullary cancer patients' supportive care needs and use of community and allied health services. Psycho-Oncology, 25 (2), 150-157. doi: 10.1002/pon.3887 |
|
2015 Journal Article Describing patterns of care in pancreatic cancer a population-based studyBurmeister, Elizabeth A., O'Connell, Dianne L., Beesley, Vanessa L., Goldstein, David, Gooden, Helen M., Janda, Monika, Jordan, Susan J., Merrett, Neil D., Payne, Madeleine E., Wyld, David and Neale, Rachel E. (2015). Describing patterns of care in pancreatic cancer a population-based study. Pancreas, 44 (8), 1259-1265. doi: 10.1097/MPA.0000000000000384 |
|
2015 Conference Publication A randomised phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours: the P3BEP Trial (Anzup 1302)Lawrence, Nicola, Toner, Guy, Martin, Andrew, Stockler, Martin, Yeung, Annie, Wong, Nicole, Thomson, Damien, Gebski, Val, Yip, Sonia, King, Madeleine, Friedlander, Michael, Quinn, David, Tan, Thean Hsiang, Chan, Howard, Hanning, Fritha, Weickhardt, Andrew, Jeffery, Mark, Stevanovic, Amanda, Hovey, Elizabeth, Wyld, David, Davis, Ian and Grimison, Peter (2015). A randomised phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours: the P3BEP Trial (Anzup 1302). COSA’s 42nd Annual Scientific Meeting. Rare Cancers: Common Goals, Hobart, Australia, 17–19 November 2015. Chichester, United Kingdom: Wiley-Blackwell. doi: 10.1111/ajco.12432_2 |
|
2015 Conference Publication Efficacy of PRRT in metastatic neuroendocrine tumors; a retrospective large single institutional studyJan, H., Wyld, D. and Burge, M. (2015). Efficacy of PRRT in metastatic neuroendocrine tumors; a retrospective large single institutional study. 12th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona Spain, Mar 11-13, 2015. Basel, Switzerland: S. Karger AG. doi: 10.1159/000431385 |
